(A) HuH7 cells were transfected with plasmids to express GFP, GFP-CD95 or GFP-CD95 YY-FF. Twenty four h after transfection cells were treated with vehicle (DMSO) or the indicated concentrations of sorafenib (Sor, µM) and/or vorinostat (Vor, 500 nM). Cells were isolated 24h after drug exposure and cell viability determined by trypan blue exclusion (n = 3 +/− SEM). *p < 0.05 greater than vehicle control; **p < 0.05 greater than corresponding value in vehicle control treated cells; #p < 0.05 less than corresponding values in CD95-GFP expressing cells.(B) HuH7 cells were transfected with plasmids to express GFP, GFP-CD95 or GFP-CD95 YY-FF. Twenty four h after transfection cells were treated with vehicle (DMSO) or the indicated concentrations of sorafenib (Sor, µM) and/or Na valproate (Val, 1 mM). Cells were isolated 24h after drug exposure and cell viability determined by trypan blue exclusion (n = 3 +/− SEM). *p < 0.05 greater than vehicle control; **p < 0.05 greater than corresponding value in vehicle control treated cells; #p < 0.05 less than corresponding values in CD95-GFP expressing cells.